Form 4: NeuroMetrix Director Goodman Receives Restricted Stock Units

Director David Goodman of NeuroMetrix, Inc. was granted 13,730 restricted stock units on May 22, 2024, vesting on the earlier of the 2025 annual meeting or a change in control.

Summary

• On May 22, 2024, David Goodman, a director of NeuroMetrix, Inc., received a grant of 13,730 restricted stock units (RSUs).
• These RSUs will vest 100% on the earlier of the date of the 2025 annual meeting of stockholders or a change in control of NeuroMetrix.
• Vesting is contingent upon Goodman's continued service on the Board of Directors until the vesting date.
• The price of the stock on April 30, 2024, was $4.37.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The grant of RSUs is a standard practice and indicates confidence in the company's future, but it's not a major event.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders, incentivizing continued service and value creation.

Future Outlook

The vesting of the restricted stock units is contingent upon continued service and a potential change in control, indicating a focus on long-term stability and potential strategic opportunities.

Industry Context

Grants of restricted stock units are a common practice in corporate governance to align the interests of directors and management with those of shareholders. This grant is typical for companies seeking to retain board members and incentivize long-term value creation.

Comparison to Industry Standards

• Stock grants to directors are a common practice across the industry.
• Companies like Medtronic and Boston Scientific also use stock grants as part of their director compensation packages.
• The vesting schedule and conditions are fairly standard, aligning with typical industry practices for director equity compensation.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns director interests with long-term company performance.

Key Dates

Keywords

restricted stock units, director, NeuroMetrix, NURO, stock options, Form 4, insider trading